Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2859972 | 0.94 | PRKCA (0.40) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL98483 | 0.93 | PRKCA (0.39) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL97381 | 0.93 | PRKCA (0.39) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL20237253 | 0.88 | PRKCA (0.36) | PRKCATSHR | |
| SCHEMBL30673065 | 0.84 | PRKCA (0.43) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL97727 | 0.84 | PRKCA (0.56) | PRKCAALDH1A1LMNA | |
| SCHEMBL1171852 | 0.83 | PRKCA (0.40) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL97997 | 0.81 | PRKCA (0.34) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL1171053 | 0.81 | PRKCA (0.41) | PRKCAMMP1MMP2MMP3MMP9 | |
| SCHEMBL4977858 | 0.79 | PRKCA (0.51) | PRKCAALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642651-A1 | PHOSPHINE OXIDE-BASED PHOTOINITIATORS | ARKEMA France (FR) | 2025-11-05 | — | — | EP | claimed |
| WO-2024141190-A1 | PHOSPHINE OXIDE-BASED PHOTOINITIATORS | ARKEMA FRANCE (FR) | 2024-07-04 | — | — | WO | claimed |
| EP-2436715-B1 | EPOXY RESIN-BASED COATING COMPOSITION | SHOWA DENKO KK (JP) | 2016-08-24 | — | — | EP | claimed |
| US-8865801-B2 | Epoxy resin-based coating composition | SHOWA DENKO K.K. (JP) | 2014-10-21 | — | — | US | claimed |
| US-8242217-B2 | Epoxy resin curing agent, process for preparing the same, and epoxy resin composition | SHOWA DENKO K.K. (JP) | 2012-08-14 | — | — | US | claimed |
| EP-2226347-B1 | EPOXY RESIN CURING AGENT, METHOD FOR PRODUCING THE SAME, AND EPOXY RESIN COMPOSITION | SHOWA DENKO KK (JP) | 2012-06-27 | — | — | EP | claimed |
| US-20120077903-A1 | EPOXY RESIN-BASED COATING COMPOSITION | SHOWA DENKO K.K. (JP) | 2012-03-29 | — | — | US | claimed |
| US-20100273940-A1 | EPOXY RESIN CURING AGENT, PROCESS FOR PREPARING THE SAME, AND EPOXY RESIN COMPOSITION | SHOWA DENKO K.K. (JP) | 2010-10-28 | — | — | US | claimed |
| EP-2226347-A1 | EPOXY RESIN CURING AGENT, METHOD FOR PRODUCING THE SAME, AND EPOXY RESIN COMPOSITION | Showa Denko K.K. (JP) | 2010-09-08 | — | — | EP | claimed |
| US-12637544-B2 | UV curable silicone composition and cured product thereof | DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4667545-A1 | PHOTOCURABLE COMPOSITION | Bostik SA (FR) | 2025-12-24 | — | — | EP | disclosed |
| EP-4667546-A1 | PHOTOCURABLE COMPOSITION | Bostik SA (FR) | 2025-12-24 | — | — | EP | disclosed |
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-4642651-A1 | PHOSPHINE OXIDE-BASED PHOTOINITIATORS | ARKEMA France (FR) | 2025-11-05 | — | — | EP | disclosed |
| US-20060079593-A1 | Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same | SHOWA DENKO K.K. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-20060041053-A1 | Color filter black matrix resist composition and carbon black dispersion composition used for the composition | SHOWA DENKO K.K. (JP) | 2006-02-23 | — | — | US | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
| US-20050258406-A1 | Black resist composition for color filter | SHOWA DENKO K.K. | 2005-11-24 | — | — | US | disclosed |
| US-20050153231-A1 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2005-07-14 | — | — | US | disclosed |
| WO-2005047346-A1 | CURABLE POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637544-B2 | UV curable silicone composition and cured product thereof | QSOX1, MGMT, TST | PRKCA 4383/4885MMP1 1528/4885MMP2 2064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.